Marketing Analysis of Hepatoprotective Drugs
American Journal Of Biomedical Science & Pharmaceutical Innovation · 10.06.2026 · 06 (06) · 15-22
DOI: 10.37547/ajbspi/volume06issue06-04 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Biomedical Science & Pharmaceutical Innovation, online erschienen am 10.06.2026. Verfasst von Hasanova D.O. und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This article provides a marketing analysis of the assortment of hepatoprotective drugs based on data from the 2023–2025 State Register of medicinal products, medical devices, and medical equipment approved for use in the Republic of Uzbekistan. During the study, using data from "Drug audit," the assortment range and market dynamics of hepatoprotective drugs produced by foreign and domestic pharmaceutical companies registered in the republic were examined. Additionally, the growth trends, competitive environment, and position in the pharmaceutical market of this group of drugs were assessed.
Zitieren
APA
D.O., H., Z.V., T., & Maxmudov, R. (2026). Marketing Analysis of Hepatoprotective Drugs. American Journal Of Biomedical Science & Pharmaceutical Innovation, 06(06), 15-22. https://doi.org/10.37547/ajbspi/volume06issue06-04
Vancouver
D.O. H, Z.V. T, Maxmudov R. Marketing Analysis of Hepatoprotective Drugs. American Journal Of Biomedical Science & Pharmaceutical Innovation. 2026;06(06):15-22. doi:10.37547/ajbspi/volume06issue06-04
BibTeX
@article{DO2026,
author = {D.O., Hasanova and Z.V., Turdiyeva and Maxmudov, R.R.},
title = {Marketing Analysis of Hepatoprotective Drugs},
journal = {American Journal Of Biomedical Science & Pharmaceutical Innovation},
year = {2026},
volume = {06},
number = {06},
pages = {15--22},
doi = {10.37547/ajbspi/volume06issue06-04}
}
EUVIMED